Search results
Results From The WOW.Com Content Network
Athersys (ATHX) gains on encouraging results from its exploratory study on the intravenous administration of MultiStem cell therapy to treat patients suffering from ARDS.
Many investors define successful investing as beating the market average over the long term. But the risk of stock...
December 14, 2023 at 4:17 AM. US stock futures gained on Thursday, as investors continued to celebrate a dovish shift by the Federal Reserve that helped propel the Dow to a new all-time closing ...
Click here for in-depth analysis of the latest stock market news and events moving stock prices. Read the latest financial and business news from Yahoo Finance. Show comments. Advertisement ...
Investors need to pay close attention to Athersys (ATHX) stock based on the movements in the options market lately.
While a mid-stage/late-stage study evaluating Athersys' (ATHX) stem cell treatment for ischemic stroke misses out on its primary endpoint, top-line data shows evidence of therapeutic impact.
S&P 500 futures also rose 0.2%, while contracts on the tech-heavy Nasdaq 100 were little changed. Stocks have surged as investors became increasingly convinced the Federal Reserve would make more ...
Click here for in-depth analysis of the latest stock market news and events moving stock prices. Read the latest financial and business news from Yahoo Finance. Show comments. Advertisement ...